A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer

BACKGROUND: Cervical cancer (CC) is a major malignancy affecting women worldwide, with limited treatment options for patients with advanced disease. The aim of this study was to identify novel prognostic biomarkers for CC. METHODS: RNA-Seq data from four Gene Expression Omnibus datasets (GSE5787, GS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun, Zheng, Hua, Han, Yatian, Wang, Geng, Li, Yanbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758149/
https://www.ncbi.nlm.nih.gov/pubmed/33381538
http://dx.doi.org/10.1155/2020/4535820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758149/
https://www.ncbi.nlm.nih.gov/pubmed/33381538
http://dx.doi.org/10.1155/2020/4535820

Ejemplares similares